Login / Signup

Observational study of azithromycin in hospitalized patients with COVID-19.

Alejandro Rodríguez-MolineroCarlos Pérez-LópezCésar Gálvez-BarrónAntonio MiñarroOscar MachoGabriela F LópezMaria Teresa RoblesMaría Dolores DapenaSergi MartínezEzequiel RodríguezIsabel Colladonull null
Published in: PloS one (2020)
We did not find a clinical benefit associated with the use of azithromycin, in terms of lung function 48 hours after treatment or length of hospital stay.
Keyphrases
  • lung function
  • cystic fibrosis
  • chronic obstructive pulmonary disease
  • air pollution
  • healthcare
  • acute care
  • adverse drug